UConn Innovation Portal– UConn alumnus Tim Myles ’14 Ph.D. (ENG) has taken advantage of several NSF I-Corps programs to help commercialize a non-invasive, clinically accurate device that detects and monitors the status of chronic illnesses through analysis of exhaled breath. Hear about his experience with I-Corps, innovation, and entrepreneurship.
Macarons in Paris
Somehow I’d gone 22 years of my life without having a macaroon. I’d known what they were, seen them in bakeries and at dinner parties, yet never taken a bite. When I came to Paris I knew I had to try one, and I wanted one from the best. Continue Reading
Professor Cohen Honored for Transportation Work
Finance and Real Estate Professor Jeffrey Cohen has received the 2017 Distinguished Member Award from the Transportation and Public Utilities Group (TPUG) of the Allied Social Sciences Associations (ASSA). The award was bestowed at the organization’s annual meeting in Philadelphia on Jan. 5. Continue Reading
BEHS Students Show Off Their Businesses at Competition
The Bristol Press– Sophomore Abigail King won the gold medal certificate for her idea for an interior design consulting business called “Intuit Interiors,” at the 15th Bristol Eastern High School Business Plan Competition (BPC), held recently at the UConn-Waterbury regional campus.
Charter Sets Sights on Original Content
Stamford Advocate– The country’s second-largest cable company wants to be more than a distributor.
Charter Communications’ announcement earlier this month that it had created and filled a new senior vice president position to oversee original content points to its increasing focus on producing its own programming. Industry experts are not surprised that Charter is focusing more on production in a shifting media landscape, but some question the effectiveness of the strategy.
Does Social Media Excel When an Industry is in Crisis?
Savvy Social Media Tactics Boosted Airline Industry Following Devastating Crash
The crash of a passenger airplane is the ultimate public relations crisis for the airline industry.
But the opportunity to explore the way a distressed airline—and its competitors—handle that crisis on social media provides an outline for many different companies on the right and wrong way to address an industry emergency, said OPIM Professor Shu He. Continue Reading
FAU Study Says Some Nursing Homes Gaming the System to Improve Their Medicare Star Ratings
PR Newswire– For families faced with the difficult decision of placing a loved one in a nursing home, a government rating system is often the only source of information to determine which facilities are the best. However, a new study of nursing homes in California, the nation’s largest system, by faculty at Florida Atlantic University and the University of Connecticut, found that some nursing homes inflate their self-assessment reporting to improve their score in the Five-Star Quality Rating System employed by Medicare to help consumers.
Professor Noble to Lead Werth Institute
Professor David Noble has been named the director of the Peter J. Werth Institute for Entrepreneurship and Innovation at UConn. (Nathan Oldham/UConn School of Business)
Business School Professor Predicts UConn is on Cusp of Powerful Entrepreneurial Growth
David Noble, a professor-in-residence in the management department at the School of Business, has been named the director of the new Peter J. Werth Institute for Entrepreneurship and Innovation at UConn. Continue Reading
Winter in Israel: Day 8
Our final day in Tel Aviv was bittersweet, as we knew our incredible journey was coming to an end. We started the day meeting at YL Ventures, a venture capital (VC) firm like many in Israel that focused on early-stage investing. I was astounded that while the US was trending towards less early/seed-stage capital and much more later-stage investments, Israel seemed to embrace their unique VC ecosystem.
Removing the Immunotherapy Blindfold
UConn Today– Immunotherapies are promising in theory, but often not in practice. In fact according to experts, they actually only work 10 percent of the time in the treatment of cancer – at best. Yet, while immunotherapy drugs may only help a minority of patients, those who do respond often do extremely well. As a result, many scientists are working to tap into the treatment’s benefits for a wider group of patients.